【动物试验显示:一种对付新冠的口服药可治愈埃博拉】美国得克萨斯大学研究团队在最近的《科学进展》杂志上报告称,感染埃博拉病毒的猴子可通过口服药物治愈。这为人类获得更实用、更经济的治疗方法开辟了新途径。此次试验中,研究团队使用了抗病毒药物奥贝德西韦(Obeldesivir)。这是原本为治疗新冠病毒感染而开发的瑞德西韦的口服版本。奥贝德西韦属于“聚合酶抑制剂”,通过阻断病毒复制所需的关键酶发挥作用。

金融界
19 Mar
美国得克萨斯大学研究团队在最近的《科学进展》杂志上报告称,感染埃博拉病毒的猴子可通过口服药物治愈。这为人类获得更实用、更经济的治疗方法开辟了新途径。此次试验中,研究团队使用了抗病毒药物奥贝德西韦(Obeldesivir)。这是原本为治疗新冠病毒感染而开发的瑞德西韦的口服版本。奥贝德西韦属于“聚合酶抑制剂”,通过阻断病毒复制所需的关键酶发挥作用。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10